Rob Missere

Rob Missere is the Managing Director of OMERS Private Capital, where he oversees the life sciences investment arm. He recently commented on the financing provided by OMERS for Zymeworks' acquisition of Theravance Biopharma, noting the strategic structure of the deal in the context of OMERS' active role in pharmaceutical royalty monetization.